Method of treating hepatitis C in non-responders to interferon t

Details Method of treating hepatitis C in non-responders to interferon t Method of treating hepatitis C in non-responders to interferon t

1993-03-05

1999-12-14

Guzo, David

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 12, A61K 3803, A61K 3816

Patent

active

060017996

ABSTRACT:
A method of treating Hepatitis C by administering an immune system-potentiating dose of at least one Thymosin or system-potentiating Thymosin fragment to a mammal infected with Hepatitis C virus, which Hepatitis C infection in the mammal is non-responsive to treatment with interferon alone.

REFERENCES:
patent: 5849696 (1998-12-01), Chretien et al.
European Search Report dated Dec. 15, 1992.
Eichberg et al., "Effect of Thymosin . . . Hepatitis B Carriers", Chemical Abst. , vol. 106, No. 15, Apr. 1987, Abst. No. 117943h pp. 487-488.
Kuo, G., et al., Science, 244:362-4 (1989).
Alter, H.H., in Zuckerman, A.J., ed., Viral Hepatitis and Liver Disease, Allen K. Liss, New York, 1988, pp. 537-42.
Kortez. R.L., et al., Gastroenterology, 88:1251-4 (1985).
Pappas, S.C., J. Med. Virol., 15:1-9 (1985).
Stokes, P., et al. Gastroenterology, 92:1783 Abstract (1987).
Hoofnagle, J.H., et al. New England Journal of Medicine, 315:1575-8 (1986).
Thomson, J., Lancet, 1:539-41 (1987).
Kiyosawa, K., et al., in Zukerman, A., ed., Viral Hepatitis and Liver Disease, Allen K. Liss, NY., 1983 pp. 895-7.
Hoffnagle, J.H., et al., Sem. Liver Dis., 9:259-263 (1985).
Low, T.L.K., et al., Thymosing: Structure, Function and Therapeutic Application:, Thymus, 6:27-42 (1984).
Goldstein, et al., Proc. Nat'l Acad. Sci. (USA), 69:1800-1803 (1972).
Wetzel, R. et al., Biochemistry, 19:6096-6104 (1980).
Low, T.L.K., et al., J. Biol. Chem., 254:981-6 (1979).
Schulof, R.S., et al., in The Lymphocyte, Allen J. Liss Inc., NY 1981, pp. 191-215.
Koutab, N.M., et al., Immunopharm., 16:97-105 (1988).
Favilli, C. et al., Cancer Immunol. Immunother., 20:189-92 (1985).
Marshall, G.D., et al., J Immunol., 126:741-4 (1981).
Baxevanis, C.N., et al., Immunopharm., 13:133-41 (1987).
Svedsky, L.P., Eur. J. Immunol., 12:244-7 (1982).
Goldstein, A.L., et al., Transp. Proc., 9:1141 (1977).
Cohen, N.H., et al., J. Amer. Med. Assoc., 241:1813-5 (1979).
Schulof, R.S., et al., J. Biol. Response Modifiers, 4:147-58 (1985).
Gravenstein, S., et al., JAGS, 37:1-8 (1989).
Korba, B.E., et al., Hepatology, 12: Abs. 880 (1990).
Weiner, A.J., et al., Lancet, 335:1-3 (1990).
Knodell, R.G., et al., Hepatology, 1:431-5 (1981).
Ulrich, P., et al., J. Clin. Invest., 86:1609-14 (1990).
Mutchnick, M.G., et al. Clin. Immunol. Immunopathol., 23:626-33 (1982).
Serrate, S.A., et al., J. Immunol., 1939:233-43 (1987).
Sztein, M.B., et al., Proc. Nat'l Acad. Sci (USA), 83:6107-6111 (1986).
Davis etal., The New England Journal of Medicine, 321:1501-1506 (1989).
C. Albert, Gastroenterology Journal Club, pp. 2-8, Apr. 1991.
Blendis, MD, Gastroenterology Journal Club, p. 12.
S.H. Caldwell, MD, Gastroenterology Journal Club, pp. 9-12, Apr. 1991.
Di Bisceglie, MD, The New England Journal of Medicine, 321:1506-1510 (1989).
P. Farci, et al., The New England Journal of Medicine, 325:98-104 (1991).
P. Marcellin, et al., Hepatology, 13:393-398 (1991).
M.J. Alter, The New England Journal of Medicine, 321:1538-1540 (1989).

Affiliated with

Also associated with

Rating

Method of treating hepatitis C in non-responders to interferon t does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating hepatitis C in non-responders to interferon t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating hepatitis C in non-responders to interferon t will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-863405